The great medicines scandal: access is not just about cost
- PMID: 16809717
- PMCID: PMC1488803
- DOI: 10.1136/bmj.333.7557.44-a
The great medicines scandal: access is not just about cost
Figures
Comment on
-
The great medicines scandal.BMJ. 2006 Jun 10;332(7554):1345-6. doi: 10.1136/bmj.38868.651736.47. Epub 2006 Jun 1. BMJ. 2006. PMID: 16740527 Free PMC article. No abstract available.
Similar articles
-
The great medicines scandal: next steps?BMJ. 2006 Jul 1;333(7557):44-5. doi: 10.1136/bmj.333.7557.44-b. BMJ. 2006. PMID: 16809716 Free PMC article. No abstract available.
-
The concept of essential medicines: lessons for rich countries.BMJ. 2004 Nov 13;329(7475):1169-72. doi: 10.1136/bmj.329.7475.1169. BMJ. 2004. PMID: 15539676 Free PMC article. Review.
-
TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.Chic J Int Law. 2002 Spring;3(1):27-46. Chic J Int Law. 2002. PMID: 15709298 No abstract available.
-
Improving access to NCD medicines through collaboration.Lancet. 2016 Apr 23;387(10029):1704-5. doi: 10.1016/S0140-6736(16)00275-0. Lancet. 2016. PMID: 27116264 No abstract available.
-
Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.Res Social Adm Pharm. 2009 Sep;5(3):286-97. doi: 10.1016/j.sapharm.2008.08.001. Epub 2009 Feb 3. Res Social Adm Pharm. 2009. PMID: 19733829 Review. No abstract available.
References
-
- Gelders S, Ewen M, Noguchi N, Laing R. Price, availability and affordability; An international comparison of chronic disease medicines. Geneva: World Health Organization and Health Action International, 2006. (WHO-EM/EDB/068/E/05.06/3000.)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical